{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:59:29Z","timestamp":1761469169647,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.transci.2022.103351","type":"journal-article","created":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T21:23:55Z","timestamp":1641504235000},"page":"103351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Outcomes of stem cell mobilization and engraftment in patients with multiple myeloma according to CD56 expression status"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7129-418X","authenticated-orcid":false,"given":"Utku","family":"Iltar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00dcnal","family":"Ata\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ece","family":"Vural","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadime Nurcan","family":"Alhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orhan Kemal","family":"Y\u00fccel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozan","family":"Salim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Levent","family":"Undar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.transci.2022.103351_bib0005","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3324\/haematol.2013.096149","article-title":"Treatment of autologous stem cell transplant-eligible multiple myeloma patients: ten questions and answers","volume":"99","author":"Mohty","year":"2014","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.transci.2022.103351_bib0010","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.bbmt.2014.05.003","article-title":"Peripheral blood progenitor cell mobilization for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation","volume":"20","author":"Duong","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"April","key":"10.1016\/j.transci.2022.103351_bib0015","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1537-2995.2011.03385.x","article-title":"Best practice for peripheral blood progenitor cell mobilization and collection in adults and children: results of a Societ\u00e0 Italiana Di Emaferesi e Manipolazione Cellulare (SIDEM) and Gruppo Italiano Trapianto Midollo Osseo (GITMO) consensus process","volume":"52","author":"Pierelli","year":"2012","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.transci.2022.103351_bib0020","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1046\/j.1365-2141.2001.02498.x","article-title":"Preceding chemotherapy, tumour load and age influence engraftment in multiple myeloma patients mobilized with granulocyte colony-stimulating factor alone","volume":"112","author":"Desikan","year":"2001","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1016\/j.transci.2022.103351_bib0025","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s002770100351","article-title":"Predictive factors for a successful mobilization of peripheral blood CD34+ cells in multiple myeloma","volume":"80","author":"Perea","year":"2001","journal-title":"Ann Hematol"},{"issue":"9","key":"10.1016\/j.transci.2022.103351_bib0030","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1038\/sj.leu.2404801","article-title":"Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma","volume":"21","author":"Kumar","year":"2007","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.transci.2022.103351_bib0035","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.transci.2008.09.012","article-title":"Factors affecting hematopoietic progenitor cell mobilization: an analysis of 307 patients","volume":"39","author":"Mendrone","year":"2008","journal-title":"Transfus Apher Sci"},{"issue":"7","key":"10.1016\/j.transci.2022.103351_bib0040","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1182\/blood.V90.7.2522","article-title":"The granulocyte colony-stimulating factor receptor is required for the mobilization of murine hematopoietic progenitors into peripheral blood by cyclophosphamide or interleukin-8 but not Flt-3 ligand","volume":"90","author":"Liu","year":"1997","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.transci.2022.103351_bib0045","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/jcb.21043","article-title":"Cytokines and hematopoietic stem cell mobilization","volume":"99","author":"Nervi","year":"2006","journal-title":"J Cell Biochem"},{"issue":"2","key":"10.1016\/j.transci.2022.103351_bib0050","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/scrt54","article-title":"Mobilization of hematopoietic stem cells from the bone marrow niche to the blood compartment","volume":"2","author":"Hoggatt","year":"2011","journal-title":"Stem Cell Res Ther"},{"issue":"4803","key":"10.1016\/j.transci.2022.103351_bib0055","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1126\/science.3576199","article-title":"Neural cell adhesion molecule: structure, immunoglobulin-like domains, cell surface modulation, and alternative RNA splicing","volume":"236","author":"Cunningham","year":"1987","journal-title":"Science (80-)"},{"issue":"4848","key":"10.1016\/j.transci.2022.103351_bib0060","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1126\/science.3281256","article-title":"The neural cell adhesion molecule (NCAM) as a regulator of cell-cell interactions","volume":"240","author":"Rutishauser","year":"1988","journal-title":"Science (80-)"},{"issue":"3","key":"10.1016\/j.transci.2022.103351_bib0065","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-2141.1991.tb08050.x","article-title":"Expression of cytoadhesion molecules (CD56, CD54, CD18 and CD29) by myeloma plasma cells","volume":"79","author":"Van Riet","year":"1991","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2022.103351_bib0070","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1046\/j.1365-2141.2002.03513.x","article-title":"Clinicopathological and prognostic characteristics of CD56-negative multiple myeloma","volume":"1","author":"Sahara","year":"2002","journal-title":"Br Soc Haematol"},{"issue":"3","key":"10.1016\/j.transci.2022.103351_bib0075","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1365-2249.1991.tb05654.x","article-title":"Expression of the neural cell adhesion molecule (CD56) by human myeloma cells","volume":"83","author":"Drach","year":"1991","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.transci.2022.103351_bib0080","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1080\/10428190802699332","article-title":"Regulation of the CD56 promoter and its association with proliferation, anti-apoptosis and clinical factors in multiple myeloma","volume":"50","author":"Damgaard","year":"2009","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1016\/j.transci.2022.103351_bib0085","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/jca.21864","article-title":"Is absence of CD56 a predictive factor for peripheral blood stem cell mobilization failure in patients with multiple myeloma?","volume":"36","author":"G\u00f6\u00e7er","year":"2021","journal-title":"J Clin Apher"},{"issue":"5","key":"10.1016\/j.transci.2022.103351_bib0090","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","article-title":"Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group","volume":"121","author":"International Myeloma Working Group","year":"2003","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.transci.2022.103351_bib0095","first-page":"213","article-title":"The ISHAGE guidelines for CD34+ cell determination by flow cytometry","volume":"5","author":"Sutherland","year":"1996","journal-title":"Int Soc Hematother Graft Eng J Hematother"},{"issue":"2","key":"10.1016\/j.transci.2022.103351_bib0100","first-page":"61","article-title":"Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines","volume":"34","author":"Keeney","year":"1998","journal-title":"Int Soc Hematother Graft Eng Cytometry"},{"issue":"10","key":"10.1016\/j.transci.2022.103351_bib0105","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00277-008-0513-9","article-title":"Contribution of neural cell adhesion molecule (NCAM) to hemopoietic system in monkeys","volume":"87","author":"Kato","year":"2008","journal-title":"Ann Hematol"},{"issue":"3","key":"10.1016\/j.transci.2022.103351_bib0110","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1182\/blood.V86.8.3151.3151","article-title":"Myeloma cells upregulate interleukin-6 secretion in osteoblastic cells through cell-to-cell contact but downregulate osteocalcin","volume":"86","author":"Barill\u00e9","year":"1995","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.transci.2022.103351_bib0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-016-0373-5","article-title":"Expression of neural cell adhesion molecule and polysialic acid in human bone marrow- derived mesenchymal stromal cells","volume":"7","author":"Skog","year":"2016","journal-title":"Stem Cell Res Ther"},{"issue":"892","key":"10.1016\/j.transci.2022.103351_bib0120","first-page":"1","article-title":"CD56 in the immune system: more than a marker for cytotoxicity?","volume":"8","author":"Van","year":"2017","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.transci.2022.103351_bib0125","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1084\/jem.169.6.2233","article-title":"Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule","volume":"169","author":"Lanier","year":"1989","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.transci.2022.103351_bib0130","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1046\/j.1365-2141.1999.01134.x","article-title":"Distribution of myeloma plasma cells in peripheral blood and bone marrow correlates with CD56 expression","volume":"104","author":"Rawstron","year":"1999","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.transci.2022.103351_bib0135","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1365-2141.2010.08121.x","article-title":"Review of phenotypic markers used in flow cytometric analysis of MGUS and MM, and applicability of flow cytometry in other plasma cell disorders","volume":"149","author":"Raja","year":"2010","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.transci.2022.103351_bib0140","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1182\/blood.V93.3.1032","article-title":"Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics","volume":"93","author":"Garc\u00eda-Sanz","year":"1999","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.transci.2022.103351_bib0145","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1038\/sj.leu.2401211","article-title":"The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma","volume":"12","author":"Pellat-Deceunynck","year":"1998","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.transci.2022.103351_bib0150","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1182\/blood.V81.10.2658.2658","article-title":"Phenotypic difference of normal plasma cells from mature myeloma cells","volume":"81","author":"Harada","year":"1993","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.transci.2022.103351_bib0155","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1182\/blood.V76.2.377.377","article-title":"Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1; Leu-19)","volume":"76","author":"Van Camp","year":"1990","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.transci.2022.103351_bib0160","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1089\/152581603322448187","article-title":"CD34+ cells and CD34+CD38- subset from mobilized blood show different patterns of adhesion molecules compared to those from steady-state blood, bone marrow, and cord blood","volume":"12","author":"Sovalat","year":"2003","journal-title":"J Hematother Stem Cell Res"},{"issue":"14","key":"10.1016\/j.transci.2022.103351_bib0165","first-page":"1535","article-title":"Differential expression of L-selectin, VLA-4, and LFA-1 on CD34+ progenitor cells from bone marrow and peripheral blood during G-CSF-enhanced recovery","volume":"23","author":"M\u00f6hle","year":"1995","journal-title":"Exp Hematol"},{"issue":"4","key":"10.1016\/j.transci.2022.103351_bib0170","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1634\/stemcells.18-4-281","article-title":"Mobilization kinetics of CD34(+) cells in association with modulation of CD44 and CD31 expression during continuous intravenous administration of G-CSF in normal donors","volume":"18","author":"Lee","year":"2000","journal-title":"Stem Cells"},{"issue":"11","key":"10.1016\/j.transci.2022.103351_bib0175","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1182\/blood.V85.11.3313.bloodjournal85113313","article-title":"Expression of adhesion molecules on CD34\u2019 cells: CD34\u2019 L-selectin+ cells predict a rapid platelet recovery after peripheral blood stem cell transplantation","volume":"85","author":"Dercksen","year":"1995","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.transci.2022.103351_bib0180","first-page":"10","article-title":"Cell adhesion molecule expression on CD34+ cells in grafts and time to myeloid and platelet recovery after autologous stem cell transplantation","volume":"26","author":"Watanabe","year":"1998","journal-title":"Exp Hematol"},{"issue":"4","key":"10.1016\/j.transci.2022.103351_bib0185","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1046\/j.1365-2141.2002.03513.x","article-title":"Clinicopathological and prognostic characteristics of CD56-negative multiple myeloma","volume":"117","author":"Sahara","year":"2002","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.transci.2022.103351_bib0190","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/sj.bmt.1705857","article-title":"Lack of CD56 expression on myeloma cells is not a marker for poor prognosis in patients treated by high-dose chemotherapy and is associated with translocation t (11;14)","volume":"40","author":"Hundemer","year":"2007","journal-title":"Bone Marrow Transpl"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050222000015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050222000015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:54:20Z","timestamp":1761468860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050222000015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1473050222000015"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2022.103351","relation":{},"ISSN":["1473-0502"],"issn-type":[{"type":"print","value":"1473-0502"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of stem cell mobilization and engraftment in patients with multiple myeloma according to CD56 expression status","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2022.103351","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103351"}}